Curriculum Vitae

PROF. DR. IDA NORMIHA BINTI HILMI

Professor
  • Department of Medicine
    Faculty of Medicine
  • i_hilmi
  • 0379492429

BIOGRAPHY

 

Ida HILMI is a Professor and Senior Consultant in Gastroenterology, University of Malaya, Kuala Lumpur, Malaysia. Prof Ida Hilmi graduated with first-class honours from the University of Glasgow in 1997. She went on to do her training in internal medicine in Oxford and obtained her Membership of the Royal Colleges of Physicians of the United Kingdom (MRCP) in 2000. She then joined the Northeast London Gastroenterology and Hepatology specialist program before returning to Malaysia in 2003. She is the current Chair of the National Hepatology and Gastroenterology Training Committee and is the President Elect for the Malaysian Society of Gastroenterology and Hepatology. Her other positions include Honorary Secretary for the Asian Education Network in IBD (IBD-AEN), Board member of the Asian Organization for Crohn’s and Colitis (AOCC) and the Malaysian lead for the IBD Emerging Nations Consortium (IBD-ENC). Her past positions include Head of the Department of Medicine, Head of Division in Gastroenterology and Hepatology and Director of Endoscopy in University of Malaya. She co-founded and was the first Chairman of the Malaysian Inflammatory Bowel Disease Special Interest Group (IBD-SIG) and is a member of several global advisory boards. She is currently a trustee for the Journal of Hepatology and Gastroenterology Foundation which is involved in medical research, education and training in gastroenterology and hepatology within the Asia-Pacific region. In terms of colorectal cancer screening, she is part of  the Rebung project which is involved in increasing awareness for the commonest cancers in Malaysia as well as improving access to screening and care, particularly in the lower income group.

Professor Hilmi’s main area of interest is inlfammatory bowel disease (IBD) and colorectal cancer screening. She is part of several international research collaborations and is currently Associate Editor for JGH Open.

ACADEMIC QUALIFICATION

  • PhD(UM)(2020), (Perubatan (Gastroenterologi))
    Universiti Malaya (UM)
  • MRCP(UK)(2000), (INTERNAL MEDICINE)
    Royal College of Physicians of Edinburgh, United Kingdom
  • MBBS(HONS)(GLASGOW)(1997), (PERUBATAN DAN PEMBEDAHAN)
    University of Glasgow, Scotland

ADMINISTRATIVE DUTIES

  • Head of Department
    19 Oct 2022 - 31 Dec 2023 (Department of Medicine, Faculty of Medicine)
  • Head of Department
    19 Oct 2020 - 18 Oct 2022 (Department of Medicine, Faculty of Medicine)
  • Head of Department
    19 Oct 2020 - 31 Dec 2022 (University Malaya)
  • Committee Members
    29 Aug 2021 - 31 Dec 2022 (National)
  • Committee Members
    01 Jan 2022 - 31 Dec 2022 (National)
  • Coordinator
    01 Jul 2020 - 30 Jun 2022 (Department of Medicine, Faculty of Medicine)
  • Alhi Jawatanjuasa Rayuan Program Ijazah Tinggi)
    20 Jun 2016 - 20 Jul 2020 (Department of Medicine, Faculty of Medicine)
  • Head of Unit
    05 Jul 2016 - 01 Jul 2020 (Department of Medicine, Faculty of Medicine)
  • Programme Coordinator
    01 Jul 2014 - 01 Jun 2020 (Department of Medicine, Faculty of Medicine)

MEMBERSHIPS

  • MALAYSIAN SOCIETY OF GASTROENTEROLOGY AND HEPATOLOGY, COMMITTEE MEMBER
    Since 2023 (National)
  • CLINICAL ENDOSCOPY JOURNAL, EDITORIAL BOARD MEMBER
    Since 2016 (International)
  • IBD EMERGING NATIONS CONSORTIUM, ACADEMIC COMMITTEE MEMBER
    Since 2016 (International)
  • ASIAN ORGANISATION OF CROHN'S AND COLITIS (AOCC), INTERNATIONAL MEMBER
    Since 2015 (International)
  • ASIA-PACIFIC CROHN'S AND COLITIS EPIDEMIOLOGY STUDY, INTERNATIONAL MEMBER
    Since 2012 (International)
  • ASIA PACIFIC INFLAMMATORY BOWEL DISEASE CONSENSUS GUIDELINES WORKING GROUP, MEMBER, STEERING COMMITTEE
    Since 2010 (International)
  • ASIA PACIFIC WORKING GROUP ON COLORECTAL CANCER, INTERNATIONAL MEMBER
    Since 2004 (International)
  • HONORARY SECRETARY ASIAN EDUCATION NETWORK IN IBD, SECRETARY
    2023 to 2023 (International)
  • COMMITTEE MEMBER NATIONAL GASTROENTEROLOGY AND HEPATOLOGY TRAINING PROGRAMME, MEMBER
    2023 to 2023 (National)
  • MALAYSIAN SOCIETY OF GASTROENTEROLOGY AND HEPATOLOGY, ACADEMIC COMMITTEE MEMBER
    Since 2003 (National)

PUBLICATIONS

Article in Journal
WoS
  1. Buie, Michael J.; Quan, Joshua; Windsor, Joseph W.; Coward, Stephanie; Hansen, Tawnya M.; King, James A.; Kotze, Paulo G.; Gearry, Richard B.; Ng, Siew C.; Mak, Joyce W. Y.; Abreu, Maria T.; Rubin, David T.; Bernstein, Charles N.; Banerjee, Rupa; Yamamoto-Furusho, Jesus K.; Panaccione, Remo; Seow, Cynthia H.; Ma, Christopher; Underwood, Fox E.; Ajuja, Vineet; Panaccione, Nicola; Shaheen, Abdel-Azi; Holroyd-Leduc, Jayna; Kaplan, Gilaad G.; Balderramo, Domingo; Chong, Vui Heng; Juliao-Banos, Fabian; Dutta, Usha; Simadibrata, Marcellus; Kaibullayeva, Jamilya; Sun, Yang; Hilmi, Ida; Ali, Raja Affendi Raja; Paudel, Mukesh Sharma; Altuwaijri, Mansour; Hartono, Juanda Leo; Wei, Shu Chen; Limsrivilai, Julajak; El Ouali, Sara; Vergara, Beatriz Iade; Dao, Viet Hang; Kelly, Paul; Hodges, Phoebe; Miao, Yinglei; Li, Maojuan (2023). Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses, CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 21(9), 2211-2221. doi:10.1016/j.cgh.2022.06.030
  2. Mak, Joyce W. Y.; Sun, Yang; Limsrivilai, Julajak; Abdullah, Murdani; Kaibullayeva, Jamilya; Balderramo, Domingo; Vergara, Beatriz Iade; Paudel, Mukesh Sharma; Banerjee, Rupa; Hilmi, Ida; Ali, Raja Affendi Raja; Wei, Shu Chen; Ng, Ka Kei; Altuwaijri, Mansour; Kelly, Paul; Yamamoto-Furusho, Jesus; Kotze, Paulo Gustavo; Ahuja, Vineet; Chong, Vui Heng; Dao, Hang Viet; Abbey, Yvonne; Ching, Jessica Y. L.; Ho, Agnes; Chan, Alicia K. W.; Bernstein, Charles; Gearry, Richard; Abreu, Maria; Rubin, David; Dotan, Iris; Hracs, Lindsay; Kaplan, Gilaad; Ng, Siew (2023). Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21), BMC MEDICAL RESEARCH METHODOLOGY. 23(1). doi:10.1186/s12874-023-01944-2
  3. Simovic, Isidora; Hilmi, Ida; Ng, Ruey Terng; Chew, Kee Seang; Wong, Shin Yee; Lee, Way Seah; Riordan, Stephen; Castano-Rodriguez, Natalia (2023). ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta-analysis on inflammatory bowel disease risk and clinical outcomes, UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. . doi:10.1002/ueg2.12477
  4. Banerjee, Rupa; Pal, Partha; Hilmi, Ida; Ghoshal, Uday C.; Desai, Devendra C.; Rahman, Mohammed Masudur; Dutta, Usha; Mohiuddin, Syed A.; Al Mohannadi, Munnera; Philip, Mathew; Ramesh, Ganesh N.; Niriella, Madunil A.; De Silva, Arjuna P.; de Silva, Hithanadura Janaka; Pisespongsa, Pises; Limsrivilai, Julajak; Aniwan, Satimai; Nawarathne, Metthananda; Fernandopulle, Nilesh; Aye, Than Than; Ni, Nwe; Al Awadhi, Sameer; Joshi, Neeraj; Ngoc, Pham Thi, V; Kieu, Tuan, V; Nguyen, Anh Duong; Abdullah, Murdani; Ali, Ezzat; Zeid, Ahmed; Sollano, Jose D.; Saberi, Bismillah; Omar, Mahmoud; Mohsin, Mostafa Noor; Aftab, Hafeza; Wai, Tin Moe; Shastri, Yogesh M.; Chaudhuri, Sujit; Ahmed, Faruque; Bhatia, Shobna J.; Travis, Simon P. L. (2022). Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. . doi:10.1111/jgh.15801
  5. Hor, Jia Wei; Lim, Shen-Yang; Khor, Eng Soon; Chong, Kah Kian; Song, Sze Looi; Ibrahim, Norlinah Mohamed; Teh, Cindy Shuan Ju; Chong, Chun Wie; Hilmi, Ida Normiha; Tan, Ai Huey (2022). Fecal Calprotectin in Parkinson's Disease and Multiple System Atrophy, JOURNAL OF MOVEMENT DISORDERS. . doi:10.14802/jmd.21085
  6. Khoo, Xin-Hui; Wong, Shin Yee; Ibrahim, Nik Razima Wan; Ng, Ruey Terng; Chew, Kee Seang; Lee, Way Seah; Wong, Zhi Qin; Raja Ali, Raja Affend; Shahrani, Shahreedhan; Leow, Alex Hwong-Ruey; Hilmi, Ida Normiha (2022). Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population, FRONTIERS IN MEDICINE. 9. doi:10.3389/fmed.2022.880937
  7. Lim, Sze Zee; Chuah, Kee Huat; Rajaram, Ruveena Bhavani; Stanley, Khoo; Shahrani, Shahreedhan; Chan, Wah Kheong; Ho, Shiaw Hooi; Hilmi, Ida Normiha; Goh, Khean Lee; Mahadeva, Sanjiv (2022). Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. . doi:10.1111/jgh.15905
  8. Nik Muhamad Affendi, Nik Arsyad; Ravindran, Sarala; Siam, Tan Soek; Leow, Alex Hwong-Ruey; Hilmi, Ida (2022). Jaundice in a Primary Sclerosing Cholangitis Patient: A New Cause in a New Era, INFLAMMATORY BOWEL DISEASES. 28(3), E29-E30. doi:10.1093/ibd/izab250
  9. Shahrani, Shahreedhan; Sooi, Choong Yeong; Hilmi, Ida Normiha; Mahadeva, Sanjiv (2022). Autoimmune hepatitis (AIH) following coronavirus (COVID-19) vaccine-No longer exclusive to mRNA vaccine?, LIVER INTERNATIONAL. 42(10), 2344-2345. doi:10.1111/liv.15350
  10. Yu, N.; Tassone, D.; Lee, T.; Phan, S.; Wu, D. M.; Zhang, J.; Wang, L.; Tjahyadi, J.; Dutt, K.; Liou, H.; Basnayake, C.; Wright, E.; Lust, M.; Niewiadomski, O.; Kamm, M. A.; Connell, W.; Thompson, A. J.; Hilmi, I.; Ali, R. A. Raja; Wei, S. C.; De Cruz, P.; Friedman, A. B.; Moore, G. T.; Van Langenberg, D.; Ding, N. (2022). 6-Thioguanine nucleotide levels and antitumor necrosis factor-alpha levels in patients with inflammatory bowel disease receiving combination therapy: A retrospective multicenter study, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 37, 135-136
  11. Koh, C. J., Lakhtakia, S., Kida, M., Lesmana, C. R. A., Ang, T. L., Vu, C. K. F., . . . Ho, K. Y. (2021). Defining the endoscopic ultrasound features of chronic pancreatitis in Asians: a multicenter validation study. Endoscopy, 53(06), 595-602. doi: 10.1055/a-1217-3112
  12. Park, S. K., Wong, Z. Q., Park, S. H., Vu, K. V., Bang, K. B., Piyachaturawat, P., . . . Park, D. I. (2021). Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study. Digestive and Liver Disease, 53(2), 196-201. doi: 10.1016/j.dld.2020.06.046
  13. Ran, Z. H., Wu, K. C., Matsuoka, K., Jeen, Y. T., Wei, S. C., Ahuja, V., . . . Qian, J. M. (2021). Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia. Journal of Gastroenterology and Hepatology, 36(3), 637-645. doi: 10.1111/jgh.15185
  14. Kee, B. P., Ng, J. G., Ng, C. C., Hilmi, I., Goh, K. L., Chua, K. H. (2020). Genetic polymorphisms of ATG16L1 and IRGM genes in Malaysian patients with Crohns disease. Journal of Digestive Diseases, 21(1), 29-37. doi: 10.1111/1751-2980.12829
  15. Laube, R., Yau, Y. K., Selinger, C. P., Seow, C. H., Thomas, A., Chuah, S. W., . . . Leong, R. W. (2020). Knowledge and Attitudes Towards Pregnancy in Females with Inflammatory Bowel Disease: An International, Multi-centre Study. Journal of Crohns & Colitis, 14(9), 1248-1255. doi: 10.1093/ecco-jcc/jjaa047
  16. Mak, J. W. Y., Tang, W., Yip, T. C. F., Ran, Z. H., Wei, S. C., Ahuja, V., . . . Ng, S. C. (2019). Stopping anti-tumour necrosis factor therapy in patients with perianal Crohns disease. Alimentary Pharmacology Therapeutics, 50(11-12), 1195-1203. doi:10.1111/apt.15547
  17. Ng, S. C., Kaplan, G. G., Tang, W., Banerjee, R., Adigopula, B., Underwood, F. E., . . . Sung, J. J. Y. (2019). Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific. American Journal of Gastroenterology, 114(1), 107-115. doi:10.1038/s41395-018-0233-2
  18. Ooi, C. J., Hilmi, I., Banerjee, R., Chuah, S. W., Ng, S. C., Wei, S. C., . . . Asia Pacific Assoc Gastroenterol, A. (2019). Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohns disease in Asia. Journal of Gastroenterology and Hepatology, 34(8), 1296-1315. doi:10.1111/jgh.14648
  19. Siew, K. S. W., Tan, M. P., Hilmi, I. N., Loch, A. (2019). Swallow syncope: a case report and review of literature. Bmc Cardiovascular Disorders, 19(1), 12. doi:10.1186/s12872-019-1174-4
  20. Gwee, K. A., Lee, W. W. R., Ling, K. L., Ooi, C. J., Quak, S. H., Dan, Y. Y., . . . Wong, C. Y. (2018). Consensus and contentious statements on the use of probiotics in clinical practice: A south east Asian gastro-neuro motility association working team report. Journal of Gastroenterology and Hepatology, 33(10), 1707-1716. doi:10.1111/jgh.14268
  21. Ng, S. C., Hilmi, I. N., Blake, A., Bhayat, F., Adsul, S., Khan, Q. R., Wu, D. C. (2018). Low Frequency of Opportunistic Infections in Patients Receiving Vedolizumab in Clinical Trials and Post-Marketing Setting. Inflammatory Bowel Diseases, 24(11), 2431-2441. doi:10.1093/ibd/izy153
  22. Park, D. I., Hisamatsu, T., Chen, M. H., Ng, S. C., Ooi, C. J., Wei, S. C., . . . Yang, S. K. (2018). Asian Organization for Crohns and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management. Journal of Gastroenterology and Hepatology, 33(1), 30-36. doi:10.1111/jgh.14018
  23. Park, D. I., Hisamatsu, T., Chen, M. H., Ng, S. C., Ooi, C. J., Wei, S. C., . . . Yang, S. K. (2018). Asian Organization for Crohns and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessment. Journal of Gastroenterology and Hepatology, 33(1), 20-29. doi:10.1111/jgh.14019
  24. Teoh, A. Y. B., Dhir, V., Kida, M., Yasuda, I., Jin, Z. D., Seo, D. W., . . . Ho, L. K. Y. (2018). Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel. Gut, 67(7), 1209-1228. doi:10.1136/gutjnl-2017-314341
  25. Suman, S., Hussin, F. A., Malik, A. S., Ho, S. H., Hilmi, I., Leow, A. H. R., Goh, K. L. (2017). Feature Selection and Classification of Ulcerated Lesions Using Statistical Analysis for WCE Images. Applied Sciences-Basel, 7(10). doi:10.3390/app7101097
  26. Chua, K. H., Ng, J. G., Ng, C. C., Hilmi, I., Goh, K. L., Kee, B. P. (2016). Association of NOD1, CXCL16, STAT6 and TLR4 gene polymorphisms with Malaysian patients with Crohns disease, Peerj. 4(17), Article
  27. Ng, S. C., Zeng, Z. R., Niewiadomski, O., Tang, W., Bell, S., Kamm, M. A., Hu, P., de Silva, H. J., Niriella, M. A., Udara, W., Ong, D., Ling, K. L., Ooi, C. J., Hilmi, I., Goh, K. L., Ouyang, Q., Wang, Y. F., Wu, K. C., Wang, X., Pisespongsa, P., Manatsathit, S., Aniwan, S., Limsrivilai, J., Gunawan, J., Simadibrata, M., Abdullah, M., Tsang, S. W. C., Lo, F. H., Hui, A. J., Chow, C. M., et al. (2016). Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia, Gastroenterology. 150(186-+), Article
  28. Ooi, C. J., Makharia, G. K., Hilmi, I., Gibson, P. R., Fock, K. M., Ahuja, V., Ling, K. L., Lim, W. C., Thia, K. T., Wei, S. C., Leung, W. K., Koh, P. K., Gearry, R. B., Goh, K. L., Ouyang, Q., Sollano, J., Manatsathit, S., de Silva, H. J., Rerknimitr, R., Pisespongsa, P., Abu Hassan, M. R., Sung, J., Hibi, T., Boey, C. C. M., Moran, N., Leong, R. W. L., Asia Pacific, A. (2016). Asia Pacific Consensus Statements on Crohns disease. Part 1: Definition, diagnosis, and epidemiology (Asia Pacific Crohns Disease Consensus-Part 1), Journal of Gastroenterology and Hepatology. 31(145-55), Review
  29. Ooi, C. J., Makharia, G. K., Hilmi, I., Gibson, P. R., Fock, K. M., Ahuja, V., Ling, K. L., Lim, W. C., Thia, K. T., Wei, S. C., Leung, W. K., Koh, P. K., Gearry, R. B., Goh, K. L., Qin, O. Y., Sollano, J., Manatsathit, S., de Silva, H. J., Rerknimitr, R., Pisespongsa, P., Abu Hassan, M. R., Sung, J., Hibi, T., Boey, C. C. M., Moran, N., Leong, R. W. L., Asia Pacific Assoc, G. (2016). Asia-Pacific consensus statements on Crohns disease. Part 2: Management, Journal of Gastroenterology and Hepatology. 31(156-68), Review
  30. Hilmi, I., Jaya, F., Chua, A., Heng, W. C., Singh, H., Goh, K. L. (2015). A First Study on the Incidence and Prevalence of IBD in Malaysia-Results From the Kinta Valley IBD Epidemiology Study, Journal of Crohns Colitis. 9(5), 404-409
  31. Ng, S. C., Tang, W., Leong, R. W., Chen, M. H., Ko, Y. N., Studd, C., Niewiadomski, O., Bell, S., Kamm, M. A., de Silva, H. J., Kasturiratne, A., Senanayake, Y. U., Ooi, C. J., Ling, K. L., Ong, D., Goh, K. L., Hilmi, I., Ouyang, Q., Wang, Y. F., Hu, P. J., Zhu, Z. H., Zeng, Z. R., Wu, K. C., Wang, X., Xia, B., Li, J., Pisespongsa, P., Manatsathit, S., Aniwan, S., Simadibrata, M., et al. (2015). Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific, Gut. 64(7), 1063-1071
  32. Sithambaram, S., Hilmi, I., Goh, K. L. (2015). The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test-A Rapid Office Based Assay Test for the Detection of Colorectal Cancer, Plos One. 10(79), Article
  33. Yoshinaga, S., Hilmi, I. N., Kwek, B. E. A., Hara, K., Goda, K. (2015). Current status of endoscopic ultrasound for the upper gastrointestinal tract in Asia, Digestive Endoscopy. 27, 2-10
  34. Chan, W. K., Ida, N. H., Cheah, P. L., Goh, K. L. (2014). Progression of liver disease in non-alcoholic fatty liver disease: A prospective clinicopathological follow-up study, Journal of Digestive Diseases. 15(10), 545-552
  35. Lau, T. P., Roslani, A. C., Lian, L. H., Chai, H. C., Lee, P. C., Hilmi, I., Goh, K. L., Chua, K. H. (2014). Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas, Bmj Open. 4(8), 11
  36. Lau, T. P., Roslani, A. C., Lian, L. H., Lee, P. C., Hilmi, I., Goh, K. L., Chua, K. H. (2014). Association between EGF and VEGF functional polymorphisms and sporadic colorectal cancer in the Malaysian population, Genetics and Molecular Research. 13(3), 5555-5561
  37. Lau, T. P., Roslani, A. C., Lian, L. H., Lee, P. C., Hilmi, I., Goh, K. L., Chua, K. H. (2014). NOD2/CARD15 variants in Malaysian patients with sporadic colorectal cancer, Genetics and Molecular Research. 13(3), 7079-7085
  38. Hilmi, I., Hartono, J. L., Pailoor, J., Mahadeva, S., Goh, K. L. (2013). Low prevalence of classical microscopic colitis but evidence of microscopic inflammation in Asian Irritable Bowel Syndrome patients with diarrhoea, Bmc Gastroenterology. 13, 6
  39. Hilmi, I., Sunderesvaran, K., Ananda, V., Sarji, S. A., Arumugam, K., Goh, K. L. (2013). Increased Fracture Risk and Osteoporosis Not Associated With Vitamin D Levels in Malaysian Patients With Inflammatory Bowel Disease, Journal of Clinical Endocrinology Metabolism. 98(6), 2415-2421
  40. Ng, S. C., Tang, W., Ching, J. Y., Goh, K. L., Hilmi, I., et al. (2013). Incidence and Phenotype of Inflammatory Bowel Disease Based on Results From the Asia-Pacific Crohns and Colitis Epidemiology Study, Gastroenterology. 145(1), 158-+
  41. Chua, K. H., Hilmi, I., Lian, L. H., Patmanathan, S. N., Hoe, S. Z., Lee, W. S., Goh, K. L. (2012). Association between inflammatory bowel disease gene 5 (IBD5) and interleukin-23 receptor (IL23R) genetic polymorphisms in Malaysian patients with Crohns disease, Journal of Digestive Diseases. 13(9), 459-465
  42. Chua, K. H., Ng, C. C., Hilmi, I., Goh, K. L. (2012). Co-inheritance of variants/mutations in Malaysian patients with Crohns disease, Genetics and Molecular Research. 11(3), 3115-3121
  43. Koo, J. H., Leong, R. W. L., Ching, J., Yeoh, K. G., Wu, D. C., Murdani, A., Cai, Q. C., Chiu, H. M., Chong, V. H., Rerknimitr, R., Goh, K. L., Hilmi, I., Byeon, J. S., Niaz, S. K., Siddique, A., Wu, K. C., Matsuda, T., Makharia, G., Sollano, J., Lee, S. K., et al. (2012). Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study, Gastrointestinal Endoscopy. 76(1), 126-135
  44. Chua, K. H., Lian, L. H., Kee, B. P., Thum, C. M., Lee, W. S., Hilmi, I., Goh, K. L., et al. (2011). Identification of DLG5 and SLC22A5 gene polymorphisms in Malaysian patients with Crohns disease, Journal of Digestive Diseases. 126(459-466), Article
  45. Hilmi, I., Hartono, J. L., Goh, K. L. (2010). Negative Perception in Those at Highest Risk - Potential Challenges in Colorectal Cancer Screening in an Urban Asian Population, Asian Pacific Journal of Cancer Prevention. 11(3), 815-822
  46. Loch, A., Hilmi, I. N., Mazam, Z., Pillay, Y., Choon, D. S. K. (2010). Differences in attitude towards cadaveric organ donation: observations in a multiracial Malaysian society, Hong Kong Journal of Emergency Medicine. 17(3), 236-243
  47. Ooi, C. J., Fock, K. M., Makharia, G. K., Goh, K. L., Ling, K. L., Hilmi, I., et al. (2010). The Asia-Pacific consensus on ulcerative colitis, Journal of Gastroenterology and Hepatology. 25(3), 453-468
  48. Chua, K. H., Hilmi, I., Ng, C. C., Eng, T. L., Palaniappan, S., Lee, W. S., Goh, K. L. (2009). Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease, Journal of Digestive Diseases. 10(2), 124-130
  49. Hilmi, I., Singh, R., Ganesananthan, S., Yatim, I., Radzi, M., Chua, A. B. S., Tan, H. J., Huang, S., Chin, K. S., Menon, J., Goh, K. L. (2009). Demography and clinical course of ulcerative colitis in a multiracial Asian population: A nationwide study from Malaysia, Journal of Digestive Diseases. 10(1), 15-20
  50. Schmidt, H. M. A., Goh, K. L., Fock, K. M., Hilmi, I., Dhamodaran, S., Forman, D., Mitchell, H. (2009). Distinct cagA EPIYA Motifs are Associated with Ethnic Diversity in Malaysia and Singapore, Helicobacter. 14(4), 256-263
  51. Mahadeva, S., Khoo, B. L., Khoo, P. S., Malik, A., Hilmi, I., Qua, C. S., Wong, C. H., Goh, K. L. (2008). Clinical impact and risk factors for percutaneous gastrostomy wound infections due to resistant organisms, International Journal of Infectious Diseases. 12(6), E149-E150
  52. Mahadeva, S., Malik, A., Hilmi, I., Qua, C. S., Wong, C. H., Goh, K. L. (2008). Transnasal Endoscopic Placement of Nasoenteric Feeding Tubes: Outcomes and Limitations in Non-Critically Ill Patients, Nutrition in Clinical Practice. 23(2), 176-181
  53. Bhewa, Y., Hilmi, I., Cheah, P. L., Navaratnam, P., Goh, K. L. (2007). Evaluation of the monoclonal stool antigen test for Helicobacter pylori in an Asian population with dyspepsia, Journal of Digestive Diseases. 8(4), 207-210
  54. Malik, A., Cheah, P. L., Hilmi, I. N., Chan, S. P., Goh, K. L. (2007). Non-alcoholic fatty liver disease in Malaysia: A demographic, anthropometric, metabolic and histological study, Journal of Digestive Diseases. 8(1), 58-64
  55. Hilmi, I., Tan, Y. M., Goh, K. L. (2006). Crohns disease in adults: Observations in a multiracial Asian population, World Journal of Gastroenterology. 12(9), 1435-1438
  56. Leung, W. K., Ho, K. Y., Kim, W. H., Lau, J. Y. W., Ong, E., Hilmi, I., et al. (2006). Colorectal neoplasia in Asia: a multicenter colonoscopy survey in symptomatic patients, Gastrointestinal Endoscopy. 64(5), 751-759
  57. Goh, K. L., Quek, K. F., Yeo, G. T. S., Hilmi, I. N., Lee, C. K., Hasnida, N., et al. (2005). Colorectal cancer in Asians: a demographic and anatomic survey in Malaysian patients undergoing colonoscopy, Alimentary Pharmacology Therapeutics. 22(9), 859-864
Scopus
  1. Affendi N.A.N.M., Ooi C.J., Hilmi I.N. (2023). Reply, Journal of gastrointestinal and liver diseases : JGLD. 32(3), 412-413. doi:10.15403/jgld-5217
  2. Hilmi I., Ooi C.J., Ahuja V., Aggarwal R. (2023). In memory of Professor KL Goh: The quintessential academic leader, Journal of gastroenterology and hepatology. 38(7), 1194-1196. doi:10.1111/jgh.16299
  3. Hilmi I.N., Nik Muhamad Affendi N.A., Shahrani S., Thalha A.M., Leow A.H.-R., Khoo X.-H. (2023). High Accuracy of a Simplified, Practical Algorithm in Differentiating Crohn's Disease from Intestinal Tuberculosis, Digestive Diseases. 41(4), 581-588. doi:10.1159/000529238
  4. Lee H.H., Park J.J., Lee B.-I., Hilmi I., Sollano J., Ran Z.H. (2023). Diagnosis of inflammatory bowel disease Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn s and Colitis meeting, Intestinal Research. 21(3), 328-338. doi:10.5217/ir.2023.00012
  5. Mak J.W.Y., Sun Y., Limsrivilai J., Abdullah M., Kaibullayeva J., Balderramo D., Vergara B.I., Paudel M.S., Banerjee R., Hilmi I., Ali R.A.R., Wei S.C., Ng K.K., Altuwaijri M., Kelly P., Yamamoto-Furusho J.K., Kotze P.G., Ahuja V., Chong V.H., Dao H.V., Abbey Y., Ching J.Y.L., Ho A., Chan A.K.W., Bernstein C.N., Gearry R.B., Abreu M., Rubin D.T., Dotan I., Hracs L., Kaplan G.G., Ng S.C., Tao Y., Rong J., Chen X., Song H., Zhou C., Mu Y., Wei W., Bai X., Aniwan S., Kitiyakara T., Harinwan K., Bunchorntavakul C., Techathuvanan K., Kijdamrongthum P., Suttichaimongkol T., Wetwittayakhlang P., Simadibrata M., Syam A.F., Larasati D., Tedjasaputra T.R., Saragih A.H., Koncoro H., Kanabayeva A., Kongyrbayeva N., Kurmangaliyeva A., Laryushina Y., Perizat T., Venera A., Aidana K., Toscani I., Nicoloff L., Howe M., Khoo X.H., Heng W.C., Singh H., Chua A., Hong K.W., Weng M.-T., Lin W.-C., Lee H.-C., Chang C.-C., Lin C.-C., Le P.H., Huang T.-Y., Sun C.-K., Yeh H.-J., Ho Y.H., AlIbrahim B., Alahmari M., Hodges P., Nsokolo B., Awuku Y., Li M., Chan K.H., Man Y.W., Yun-Sze T.W., Fong A. (2023). Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21), BMC Medical Research Methodology. 23(1). doi:10.1186/s12874-023-01944-2
  6. Zhang Y.-Y., Vimala R., Chui P.L., Hilmi I.N. (2023). A Systematic Review of Exercise Therapy for Bowel Preparation: Evidence to Guide Practice, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates. 46(5), 393-403. doi:10.1097/SGA.0000000000000759
  7. Khoo X.-H., Wong S.Y., Ibrahim N.R.W., Ng R.T., Chew K.S., Lee W.S., Wong Z.Q., Raja Ali R.A., Shahrani S., Leow A.H.-R., Hilmi I.N. (2022). Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population, Frontiers in Medicine. 9. doi:10.3389/fmed.2022.880937
  8. Lim S.Z., Chuah K.H., Rajaram R.B., Stanley K., Shahrani S., Chan W.K., Ho S.H., Hilmi I.N., Goh K.L., Mahadeva S. (2022). Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study, Journal of Gastroenterology and Hepatology (Australia). 37(9), 1732-1740. doi:10.1111/jgh.15905
  9. Banerjee, R., Chuah, S. W., Hilmi, I. N., Wu, D. C., Yang, S. K., Demuth, D., . . . Adsul, S. (2021). Efficacy and safety of vedolizumab in Crohn s disease in patients from Asian countries in the GEMINI 2 study. Intestinal Research, 19(1), 83-94. doi: 10.5217/ir.2019.09160
  10. Ooi, C. J., Hilmi, I. N., Kim, H. J., Jalihal, U., Wu, D. C., Demuth, D., . . . Adsul, S. (2021). Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study. Intestinal Research, 19(1), 71-82. doi: 10.5217/IR.2019.09159
  11. Hilmi, I., & Kobayashi, T. (2020). Capsule endoscopy in inflammatory bowel disease: When and how. Intestinal Research, 18(3), 265-274. doi:10.5217/IR.2019.09165
  12. Kee, B. P., Ng, J. G., Ng, C. C., Hilmi, I., Goh, K. L., Chua, K. H. (2020). Genetic polymorphisms of ATG16L1 and IRGM genes in Malaysian patients with Crohns disease. Journal of Digestive Diseases, 21(1), 29-37. doi:10.1111/1751-2980.12829
  13. Ling, K. L., Hilmi, I., Raja Ali, R. A., Leong, R. W. L., Leung, W. K., Ng, S. C., . . . Ooi, C. J. (2020). Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic. JGH Open, 4(3), 320-323. doi:10.1002/jgh3.12362
  14. Sanagapalli, S., Ko, Y., Kariyawasam, V., Ng, S. C., Tang, W., Silva, H. J., . . . Leong, R. W. (2018). The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intestinal Research, 16(3), 409-415. doi: 10.5217/ir.2018.16.3.409
  15. Lee, W. S., Azmi, N., Ng, R. T., Ong, S. Y., Ponnampalavanar, S. S. L., Mahadeva, S., Hilmi, I. (2017). Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy. Intestinal Research, 15(4), 524-528. doi: 10.5217/ir.2017.15.4.524
  16. Paramasivam, R. K., Ho, S. H., Abdullah, B. J., Goh, K. L., Hilmi, I. (2014). Novel use of a self-expandable metal stent with an anti-migration system for palliative drainage of a pancreatic cystic neoplasm, Journal of the Pancreas. 15(5), 508-511
  17. Chan, R. S., Vijayananthan, A., Kumar, G., Hilmi, I. N. (2012). Imaging findings of extensive splenic infarction after cyanoacrylate injection for gastric varices - a case report, Medical Journal of Malaysia. 67(4), 424-42503005283 (ISSN).
  18. Hilmi, I., Hartono, J. L., Goh, K. L. (2010). Negative perception in those at highest risk - Potential challenges in colorectal cancer screening in an urban Asian population, Asian Pacific Journal of Cancer Prevention. 11(3), 815-82215137368
  19. Ooi, C. J., Fock, K. M., Makharia, G. K., Goh, K. L., Ling, K. L., Hilmi, I., et al. (2010). The Asia-Pacific consensus on ulcerative colitis, Journal of Gastroenterology and Hepatology. 25(3), 453-46808159319
  20. Chua, K. H., Hilmi, I., Ng, C. C., Eng, T. L., Palaniappan, S., Lee, W. S., et al. (2009). Identification of NOD2/CARD15 mutations in Malaysian patients with Crohns disease, Journal of Digestive Diseases. 10(2), 124-130
  21. Hilmi, I., Singh, R., Ganesananthan, S., Yatim, I., Radzi, M., Chua, A. B. S., et al. (2009). Demography and clinical course of ulcerative colitis in a multiracial Asian population: A nationwide study from Malaysia, Journal of Digestive Diseases. 10(1), 15-20
  22. Schmidt, H. M. A., Goh, K. L., Fock, K. M., Hilmi, I., Dhamodaran, S., Forman, D., et al. (2009). Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore, Helicobacter. 14(4), 256-263
  23. Mahadeva, S., Malik, A., Hilmi, I., Qua, C. S., Wong, C. H., Goh, K. L. (2008). Transnasal endoscopic placement of nasoenteric feeding tubes: Outcomes and limitations in non-critically ill patients, Nutrition in Clinical Practice. 23(2), 176-181
  24. Bhewa, Y., Hilmi, I., Cheah, P. L., Navaratnam, P., Goh, K. L. (2007). Evaluation of the monoclonal stool antigen test for Helicobacter pylori in an Asian population with dyspepsia, Journal of Digestive Diseases. 8(4), 207-210
  25. Malik, A., Cheah, P. L., Hilmi, I. N., Chan, S. P., Goh, K. L. (2007). Non-alcoholic fatty liver disease in Malaysia: A demographic, anthropometric, metabolic and histological study, Multiphase Pumping and Technologies Conference and Exhibition 2007. 8(1), 58-64
  26. Hilmi, I., Goh, K. L. (2006). Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs, Chinese Journal of Digestive Diseases. 7(1), 1-6
  27. Hilmi, I., Tan, Y. M., Goh, K. L. (2006). Crohns disease in adults: Observations in a multiracial Asian population, World Journal of Gastroenterology. 12(9), 1435-1438
  28. Goh, K. L., Quek, K. F., Yeo, G. T. S., Hilmi, I. N., Lee, C. K., Hasnida, N., et al. (2005). Colorectal cancer in Asians: A demographic and anatomic survey in Malaysian patients undergoing colonoscopy, Alimentary Pharmacology and Therapeutics. 22(9), 859-864
Others
  1. Lee, W.-S., Azmi, N., Ng, R.-T., Ong, S.-Y., Ponnampalavanar, S.S.L., Mahadeva, S., Hilmi, I. (2017) Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy. Intestinal Research, 15 (4), 524-528.

RESEARCH PROJECT

National
  1. 2023 - 2026, Fundamental Research Grant Scheme (FRGS)
    Identification Of Risk Factors And The Development Of A Novel Exposome Risk Score For Inflammatory Bowel Disease In Malaysia ( Principal Investigator(PI))
  2. 2022 - 2024, Government Agency - Manage by UMCARES
    Rebung 2.0: Smart Navigation Of The Early Cancer Diagnosis Care Pathway Extension Of Rebung Into Kg Cempaka & Seri Setia ( Co-Researcher)
  3. 2021 - 2022, Private Funding - Manage by UMCARES
    Cancer Multisectoral Collaboration Network In Implementing A Pilot Cancer Early Dectection Community Project To Reduce Breast And Other Cancers Early Diagnosis Barriers In The Urban B40 Group In Taman Medan Pj ( Co-Researcher)
  4. 2017 - 2020, UM Grant - Frontier Research Grant
    Genetic Analysis And Association Of Lmna Gene In Malaysian Patients With Dilated Cardiomyopathy ( Co-Researcher)
  5. 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE IN MALAYSIA ( Principal Investigator(PI))
  6. 2009 - 2011, Geran Penyelidikan Universiti Malaya (UMRG)
    PREVALENCE OF MICROSCOPIC COLITIS AMONG PREDOMINANT DIARRHEA IRRITABLE BOWEL SYNDROME (IBS-D), FUNCTIONAL DIARRHEA AND HEALTHY CONTROL SUBJECTS ( Principal Investigator(PI))
  7. 2009 - 2010, Postgraduate Research Grant (PPP) - Research
    PREVALENCE OF OSTEOPOROSIS IN INFLAMMATORY BOWEL DISEASE
  8. 2007 - 2008, RU Geran
    DIFFERENTIAL EXPRESSED GENE INDENTIFICATION IN COLORECTAL CARCINOMA IN THE MALAYSIAN POPULATION. ( Principal Investigator(PI))
  9. 2021 - 2028, ARENA PHARMACEUTICALS, INC
    A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF ORAL ETRASIMOD AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE ( Principal Investigator(PI))
  10. 2021 - 2025, Johnson & Johnson Sdn. Bhd.
    A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants with Moderately to Severely Active Ulcerative Colitis. ( Principal Investigator(PI))
  11. 2005 - 2020, Research grant obtained by Chua Kek Heng
    Identification of disease predisposing mutations in Malaysian patients with Crohn's disease ( Consultant)
  12. 2017 - 2019, NONE
    Role and prevalence of TPMT and other thiourine metabolism associated polyporphisms in Malaysian patients with IBD intolerant to azathioprine ( Principal Investigator(PI))
  13. 2016 - 2018, NONE
    Differentiation between intestinal tuberculosis and Crohn's disease ( Principal Investigator(PI))
  14. 2012 - 2017, High Impact Research (HIR)
    Evaluating the effectiveness of a screening strategy using quantitative FIT to stratify and prioritise urgency of colonoscopy referral ( Consultant)
  15. 2008 - 2009, Short Term Research Fund (Vote F)(PJP)
    Identification of differentially expressed genes in colorectal carcinoma in the Malaysian population ( Consultant)
International
  1. 2020 - 2024, International Funding
    Ibd Gives-21: Global Ibd Visualization Of Epidemiolgy Studies In The 21st Century ( Principal Investigator(PI))
  2. 2021 - 2024
    IBD GIVES-21: Global IBD Visualization of Epidemiology Studies in the 21 st Century , The Chinese University of Hong Kong ( Co-Researcher)
  3. 2015 - 2022, International Funding
    Long Term Safety Follow Up Study on Vedolizumab in Moderate to Severe Inflammatory Bowel Disease ( Principal Investigator(PI))
  4. 2017 - 2022, International Funding
    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severe Active Ulcerative Colitis (U-achieve study) ( Principal Investigator(PI))
  5. 2017 - 2022, International Funding
    A Phase III Multicenter, Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis (UC) (U-ACTIVATE ) ( Principal Investigator(PI))
  6. 2018 - 2021, International Funding
    A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 2) ( Principal Investigator(PI))
  7. 2019 - 2021, International Funding
    A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI) ( Principal Investigator(PI))
  8. 2018 - 2021, International Funding
    A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis (LUCENT 3) ( Principal Investigator(PI))
  9. 2004 - 2020, Olympus International (obtained by Dr Joseph Sung)
    Epidemiology of Colorectal Carcinoma in the Asia Pacific Region ( Consultant)
  10. 2016 - 2020, ECCO grant
    Identification of trans-ethnic molecular signatures in Inflammatory Bowel Disease ( Consultant)
  11. 2015 - 2020, International Funding
    Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicentre Study To Evaluate The Efficacy (Introduction Of Remission) And Safety Of Etrolizumab Compared With Adalimumab And Placebo In Patients With Moderate To Severe Ulcerative Colitis Who Are Naive To Tnf Inhibitors ( Principal Investigator(PI))
  12. 2018 - 2020, International Funding
    An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) ( Principal Investigator(PI))
  13. 2017 - 2019, International Funding
    Phase III Study on Efficacy of Filgotinib in Moderate to Severe Crohn's Disease (Diversity Study) ( Principal Investigator(PI))
  14. 2017 - 2017, International Funding
    A Phase III, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of mongersen (GED-0301) for the treatment of subject with active Crohn's Disease (REVOLVE) ( Principal Investigator(PI))
  15. 2008 - 2010, Millenium Pharmaceuticals
    Phase 3, Randomzied, Placebo Controlled Trial of the Induction and Maintenance of Clinical Response by MLN002 in Moderate to Severe Ulcerative Colitis and Crohn's disease ( Principal Investigator(PI))
  16. 2009 - 2010, NONE
    Knowledge, attitude, perception towards colorectal cancer screening in Malaysia ( Principal Investigator(PI))
  17. 2004 - 2007, New South Wales Cancer Grant (obtained by Dr Hazel Mitchell)
    Interaction between host polymorphisms and Helicobacter pylori in gastric cancer patients ( Consultant)
University
  1. 2020 - 2023, Private Funding
    Effectiveness Of A Clinical Decision Support System To Improve Compliance To Post Polypectomy Surveillance Guidelines ( Co-Researcher)
  2. 2009 - 2010, Short Term Research Fund (Vote F)(PJP)
    Incidence of microscopic colitis in patients with diarrhoea predominant irritable bowel syndrome in the Malaysian population ( Principal Investigator(PI))

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2022) Commitee for Clinic of Promotion, University, (Reviewer)
  2. (2021) External Assessor's Report for Promotion, National, (External Evaluator)
  3. (2020) External Evaluator for Promotion UKM, University, (External Assessor)
  4. (2015) Title: Biomarker(s) for assessment of Villous abnormalities in Patients with Celiac Disease and other enteropathies Candidate: Alka Kumari Affiliation: All India Institute of Medical Sciences, New Delhi, India, (External Examiner)
  5. (2013) Biomarkers for Hepatocellular Carcinoma in Malaysian Patients with Chronic Hepatitis B Candidate: Behnaz Riazalhosseini MHA120016 , (Internal Examiner)
Contribution to external organisation
  1. (2023) Committee Member National Gastroenterology and Hepatology Training Programme, National, (Technical Advisor)
  2. (2022) Course Developer for Ibd Preceptorship Programme 2022, National, (Resource Person)
  3. (2022) Pfizer Emerging Markets Gi Virtual Advisory Board, International, (Resource Person)
  4. (2022) International Scientific Committee, International, (Resource Person)
  5. (2022) Content Advisor, National, (Resource Person)
  6. (2022) National Gastroenterology and Hepatology Training Committee, National, (Resource Person)
  7. (2021) Sea Inflammatory Bowel Disease Virtual Advisory Board Meeting, International, (Expert Advisor)
  8. (2021) Vedolizumab Advisory Board Meeting, National, (Expert Advisor)
  9. (2021) Inflammatory Bowel Disease Multidisciplinary Meeting, National, (Academic Appointment )
  10. (2011) Asia Pacific Consensus for the Diagnosis and Management of Crohn's Disease, Asia Pacific IBD Consensus Working Group, International
  11. (2010) Asia Pacific Consensus on Diagnosis and Management of Ulcerative Colitis, Asia Pacific IBD Working Group, International
Contribution to event
  1. (2021) International Scientific Committee, International, (Event Organiser)
  2. (2021) Speaker, International, (Panelist/Moderator)
  3. (2021) Scientific Committee, International, (Event Organiser)
  4. (2021) Speaker, International, (Panelist/Moderator)
  5. (2021) Speaker, International, (Panelist/Moderator)
  6. (2021) Speaker, International, (Panelist/Moderator)
  7. (2021) Speaker/Chair, National, (Panelist/Moderator)
Media appearance
  1. (2022) Public Awareness On Inflammatory Bowel Disease, National, (Interview)
  2. (2021) Bfm Radio Open Clinic, National, (Interview)
  3. (2021) Wanita Hari Ini - Dispepsia, National, (Interview)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2024) Effects of Abdominal Vibration Combined with Walking Exercise as an Adjunct to Standard Bowel Preparation in Older Patients with Constipation, ZHANG YUANYUAN
  2. (2013) Automated detection and analysis of high resolution wireless capsule endoscopy for small bowel disease, Shipra Suman (M0100606)
  3. (2012) Role of T-Regulatory Cells In Inflammatory Bowel Disease, Nazri bin Mustaffa (A0800114)
Master
  1. (2019) Exploratory study looking at attitude and perception to surgery among patients with inflammatory bowel disease, Kossalavani Shanmugam
  2. (2018) The impact of short message system (SMS) Reminder System on the Quaity of Bowel Preparation and Colonoscopy Appointment Adherence, Tan Wen Hao
  3. (2016) Accuracy of Endoscopic Ultrasound In The Diagnosis of Common Bile Duct Stones, Cheah Churn CHoong
  4. (2014) Knowledge, Attitudes and Practice Among Patients with Inflammatory Bowel Disease in University Malaya Medical Centre., Nor Suraya Samsudin
  5. (2010) Prevalence of dysplasia in Malaysian patients with ulcerative colitis, Dr Mohd Sennikatty
  6. (2009) Prevalence of osteoporosis in patients with inflammatory bowel disease, Sunderesvaran K
  7. (2006) Evaluation Of The Stool Antigen Test Hpstar In The Diagnosis Of Helicobacter Pylori, Dr Yusof Bhewa (University of Malaya (UM))
  8. (2003) Non Alcoholic Fatty Liver Disease In Malaysia; A Demographic, Metabolic And Histological Study, Dr Abdul Malik Jamal Buhari (University of Malaya (UM))
Under Graduate Students
  1. (2022) CLINICAL FELLOWSHIP
  2. (2006) Epidemiology Of Asymptomatic Patients Undergoing Screening Endoscopy For Colorectal Carcinoma
  3. (2005) Incidence Of Advanced Neoplasms In Patients Undergoing Surveillance For Colorectal Carcinoma
  4. (2003) Prevalence Of Malnutrition Among Medical Patients
  5. (2003) Endoscopic Findings In Patients with Upper Gastrointestinal Bleed
  6. (2003) Assessment Of Nutritional Status (Using Sga) In Patients With Chronic Liver Disease

TEACHING

Master
  1. (2022) MMed - Master in Internal Medicine
  2. (2021) NA - Master of Internal Medicine (Mmed)
  3. (2018) NK - Masters in Internal Medicine
Bachelor
  1. (2022) UMMP - Ummp Stage 2 Cohort 2020
  2. (2022) UMMP - Ummp Stage 3.3 Cohort 2017
  3. (2021) NA - University Malaya Medical Programme (Ummp) Stage 3.3
  4. (2019) MBBS - Program Ijazah Sarjana Muda Perubatan dan Sarjana Muda Pembedahan
  5. (2013) DXED3102 - Human Disease
  6. (2011) DXED3102 - Human Disease
  7. (2010) DXED3102 - Human Disease